中国制造2025:实现技术领先的代价研究报告(英文版)different stages of the same process Made in China 2025: The Cost of Technological Leadership cent, 164 suggesting that China has comfortably surpassed its basic targets. It is difficult to assess the technical EU remain at a minimum, in the long-term EU exports to China are likely to continue declining. 164 China's pharmaceutical industry's R&D investment has increased by over 20% annually since the 14 th10 积分 | 51 页 | 2.82 MB | 4 月前3
共 1 条
- 1
